…work. The article answers the question, Why Is the Tissue Bank So Important for Melanoma Research? Dr. Kashani-Sabet is the…

…AIM at Melanoma. Thank you, Melanie. The second story is about melanoma survivor, Mark Lewis, who at 62 years old…

…director of the volunteer program at the cancer center. And in 2012, she became Dr. Kirkwood’s administrator in the melanoma…

…them that few people do. Erika—and her memorable laughter and love—passed away on November 15, 2022, at the age of…

…approved for use in melanoma, no successful approach to treating advanced melanoma existed. Although chemotherapy has existed for many decades,…

…growing field of cell therapy, there are more opportunities than ever to find a treatment that fits your path forward.…

The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…

…have melanoma, neither should you. Lafontaine was originally diagnosed with Stage II melanoma on July 25, 2016.  After the cancer…

…the community. They selected melanoma in 2018. Work began immediately. Right away, they felt that a patient story would impact…

Source: University of Pittsburgh (September 20, 2021) An immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage…